Medical Equipment

Joint Pain Injections Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the joint pain injections market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Joint Pain Injections Market And What Value Is Projected For 2029?

The market for joint pain injections has experienced robust expansion in recent years. Projections indicate a rise from $5.6 billion in 2024 to $6.12 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. This historical growth is attributable to factors such as an expanding aging population, the prevalence of arthritis, worldwide health initiatives, the digitalization of healthcare, and heightened awareness regarding chronic pain management.

The joint pain injections market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $9.77 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.4%. Factors contributing to this growth during the forecast period include the broader adoption of telehealth services, tailored pain management approaches, enhanced patient education and empowerment, environmentally conscious healthcare practices, and the role of nutritional support. Key trends anticipated within this period encompass advancements in regenerative medicine, customized pain management strategies, novel injection materials, the evolution of rehabilitation technologies, and artificial intelligence AI-enhanced injection techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

What Factors Are Boosting The Joint Pain Injections Market?

The expanding occurrence of arthritis and musculoskeletal disorders is projected to boost the growth of the joint pain injections market. Globally, musculoskeletal disorders are recognized as the primary cause of disability, with low back pain being the single most common source of impairment across 160 nations. Patients receive injections to achieve pain relief and manage inflammatory conditions. For instance, in June 2023, the Australian Institute of Health and Welfare, a government body in Australia, reported that rheumatoid arthritis accounted for 2.0% of the entire disease burden and 16% of the total disease burden linked to musculoskeletal conditions. In 2022, this condition was responsible for 1,322 deaths, or 5.1 deaths per 100,000 people, representing 0.7% of all deaths. Hence, the increasing prevalence of arthritis and musculoskeletal disorders propels the joint pain injections market.

What Are The Core Segmentation Criteria In The Joint Pain Injections Market?

The joint pain injectionsmarket covered in this report is segmented –

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of Injections

2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types

3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections

2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections

3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections, Allogeneic PRP Injections

4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections, Placental Derived Cell Injections

5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections, Stem Cell Injections, Genetically Engineered Cell Injections

Which Emerging Trends Are Reshaping The Joint Pain Injections Market Landscape?

Leading companies in joint pain injections are concentrating on developing innovations, such as single-injection formulations, which prioritize patient convenience. A single-injection formulation describes a drug delivery system designed to deliver a specific dose of medication in one injection, offering sustained therapeutic effects over an extended period without requiring multiple doses. For example, in July 2024, LG Chem Ltd., a South Korea-based chemicals company, introduced Synovian, a new knee osteoarthritis treatment in China that provides a convenient single-injection formulation, making it the first of its kind in the country. This product aims to enter a significant market valued at approximately KRW 200 billion (around USD 150 million). Developed with proprietary technology, it exemplifies innovation in catering to patient needs. The primary goal is to deliver effective relief with minimal administrative difficulty.

Which Players Are Shaping The Competitive Landscape Of The Joint Pain InjectionsXX Market?

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

What Regional Trends Are Shaping Growth In The Joint Pain Injections Market?

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=6482&type=smp

Browse Through More Reports Similar to the Global Joint Pain Injections Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795